Global Bioprocess Containers Market Size, Share, By Product (2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers & Accessories), By Application (Upstream Processes, Downstream Processes, and Process Developments), By End User (Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 - 2035.

Global Bioprocess Containers Market Insights Forecasts to 2035

• The Global Bioprocess Containers Market Size Was Estimated at USD 5.162 Billion in 2025
• The Market Size is Expected to Grow at a CAGR of around 22.8% from 2026 to 2035
• The Worldwide Bioprocess Containers Market Size is Expected to Reach USD 40.239 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global bioprocess containers market size was worth around USD 5.162 billion in 2025 and is predicted to grow to around USD 40.239 billion by 2035 with a compound annual growth rate (CAGR) of 22.8% from 2026 to 2035. Global innovation in single-use systems, advanced polymer materials, integrated monitoring sensor, automation and real-time analytics with modular designs allowing flexible and scalable operations are all driving opportunities in the bioprocess containers market. 

Market Overview
The bioprocess containers market refers to the global industry involved in the production, distribution, and use of specialized containers by biopharmaceutical manufacturers to store, transport, and process biological materials such as cells, vaccines, and biologics. These containers include single-use bags, storage tanks, mixing vessels, and tubing systems that maintain sterility, protect product integrity, and support scalable production. The market is driven by the increasing adoption of single-use technologies, rising demand for flexible bioprocessing systems, advancements in materials, and the integration of real-time contamination monitoring systems. Additionally, the growing production of biologics, cell therapies, and vaccines is creating significant opportunities for market growth.

Government organizations support biopharmaceutical research by providing funding, establishing regulatory frameworks, and offering incentives that promote the adoption of safe and efficient manufacturing technologies. These initiatives drive innovation, ensure quality standards, and enable the broader use of bioprocess containers across the pharmaceutical and biotechnology industries. For instance, in September 2024, India’s Union Cabinet approved the Bio-RIDE scheme with a total outlay of INR 9,197 crore for the period 2021–22 to 2025–26, aimed at advancing biotechnology research, product development, biomanufacturing, and biofoundry infrastructure, thereby strengthening capabilities relevant to bioprocessing scale-up.

In January 2024, the U.S. Department of Defense launched the Distributed Bioindustrial Manufacturing Program to support the development of domestic biomanufacturing facilities. This program provides operational support for facilities utilizing flexible bioprocessing systems, including bioprocess containers.

Report Coverage

This research report categorizes the bioprocess containers market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the bioprocess containers market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the bioprocess containers market.  

Driving Factors

Rapid technological innovation is one of the main drivers of the bioprocess containers market's growth. Increasing demand for biologics, vaccines, gene therapies, and the industry shift towards single-use systems drives the market. The field of research advances through innovation and investment as scientists develop new materials and real-time monitoring tools which improve process control capabilities, researchers need bioprocessing systems that can easily adjust to different production needs, and pharmaceutical companies adopt greater automation, research development funding increases, and government regulations together with funding strategies support businesses that implement secure and effective production methods. Global CMO expansion together with increased awareness about process efficiency drives market growth and technology adoption in the industry.

Restraining Factors

High initial costs of single-use systems, limited reusability, variability in material quality, concern over plastic waste and environmental impact, strict regulatory compliance, supply chain disruptions, material incompatibilities, and the need for specialized training for staff are the main factors restricting the bioprocess containers market.

Market Segmentation

The bioprocess containers market share is classified into product, application, and end user.  

• The 2D bioprocess containers segment dominated the market in 2025, approximately 47%, and is projected to grow at a substantial CAGR during the forecast period.

Based on the product, the bioprocess containers market is divided into 2D bioprocess containers, 3D bioprocess containers, and other containers & accessories. Among these, the 2D bioprocess containers segment dominated the market in 2025, approximately 47%, and is projected to grow at a substantial CAGR during the forecast period. Widespread adoption in large-scale biopharmaceutical manufacturing, ease of integration with existing single-use systems, cost-effectiveness, and offer efficient space utilization, reliable sterility, and compatibility with mixing, storage, and transport processes is driving the 2D bioprocess containers industry.

• The upstream processes segment accounted for the largest share in 2025, approximately 57%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the bioprocess containers market is divided into upstream processes, downstream processes, and process developments. Among these, the upstream processes segment accounted for the largest share in 2025, approximately 57%, and is anticipated to grow at a significant CAGR during the forecast period. The increasing demand for biologics, vaccines, and gene therapies, ensure sterility, reduce contamination risk, and simplify scale-up, making them essential for efficient production, and requires large volumes of sterile containers is driving the upstream processes industry.

• The pharmaceutical & biopharmaceutical companies segment accounted for the highest market revenue in 2025, approximately 60%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the bioprocess containers market is divided into pharmaceutical & biopharmaceutical companies, CROs & CMOs, academic & research institutes, and others. Among these, the pharmaceutical & biopharmaceutical companies segment accounted for the highest market revenue in 2025, approximately 60%, and is anticipated to grow at a significant CAGR during the forecast period. Large-scale production of biologics, vaccines, and gene therapies, requiring high volumes of reliable containers, significant R&D and manufacturing investments, and regulatory requirements for process efficiency and contamination control bolstering pharmaceutical & biopharmaceutical companies market.

 Regional Segment Analysis of the Bioprocess Containers Market

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the bioprocess containers market over the predicted timeframe.

North America is anticipated to hold the largest share of the bioprocess containers market over the predicted timeframe. Strong government backing for R&D, particularly in biologics, cell and gene therapies, and vaccines are what propel North America. The region's position is further reinforced by presence of major pharmaceutical and biopharmaceutical companies together with regulatory frameworks and government initiatives in the U.S. and Canada create an environment that supports innovation while companies adopt advanced bioprocessing technologies. The region maintains its operational advantages through established network of contract research organizations and contract manufacturing organizations which support companies in production needs and adaptable manufacturing requirements. North America maintains its leading position due to high awareness of contamination risks, strict quality standards, and availability of skilled workforce.

Government initiatives include Canada’s March 2023, Biomanufacturing and Life Sciences Strategy Expansion invested in strengthening domestic biomanufacturing and vaccine production capacity, including funding for facilities and innovation supporting the market growth and the U.S.NBBI to boost the U.S. bioeconomy, September 2022, focusing on scaling biomanufacturing capacity, innovation, and supply chain resilience increasing demand for single-use bioprocess containers and systems.

Asia Pacific is expected to grow at a rapid CAGR in the bioprocess containers market during the forecast period. The biopharmaceutical manufacturing capacity in China, India, Japan, and South Korea, which rapidly expand its production facilities, as markets expand, require flexible bioprocess containers for increasing biopharmaceutical manufacturing needs. The combination of government support for healthcare infrastructure and biotechnology projects with affordable manufacturing capabilities and an increasing presence of contract manufacturing organizations drives industry expansion in Asia Pacific region.

Government launches include India’s BioE policy, 2024, to invest in shared biomanufacturing infrastructure and biofoundries through public-private partnerships. This directly supports large-scale biologics production, increasing demand for bioprocess containers and South Korea’s April 2024 Advanced Bio Initiative to promote biomanufacturing, synthetic biology, and digital bio industries, strengthening production ecosystems that rely on single-use systems.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the bioprocess containers market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation
• Merck KGaA
• Saint-Gobain Life Sciences
• Avantor, Inc.
• Lonza Group AG
• Meissner Filtration Products, Inc.
• Entegris, Inc.
• Corning Incorporated
• Parker Hannifin Corporation
• Single Use Support GmbH
• Eppendorf AG
• ALLpaQ Packaging Group
• CellBios Healthcare & Life Sciences
• Others

 Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments
• In December 2025, Thermo Fisher Scientific announced the expansion of its Bioprocess Design Centers network in Asia, including Hyderabad, India. This expansion will enable the company to provide enhanced technical support and develop localized process design solutions for its growing market operations.

• In April 2025, Thermo Fisher Scientific introduced the 5 L DynaDrive Single-Use Bioreactor, a bench-scale system designed to enhance productivity and scalability while reducing operational costs in bioprocessing. The system supports smooth transitions from 1 liter to commercial production scales, enabling faster process development.

• In June 2024, Thermo Fisher Scientific launched biodegradable film products made from botanical materials for its single-use bioprocess containers. These materials have received ISCC PLUS certification, helping to reduce the environmental impact of biopharmaceutical manufacturing.

• In April 2024, Saint-Gobain introduced Freeze-Pak STS Bio-Containers and Shippers, designed for the cold chain transportation of biological materials requiring ultra-low temperatures. These products complement the company’s existing bioprocess container portfolio for specialized transportation needs.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the bioprocess containers market based on the below-mentioned segments: 

Global Bioprocess Containers Market, By Product

• 2D Bioprocess Containers
• 3D Bioprocess Containers
• Other Containers & Accessories

Global Bioprocess Containers Market, By Application

• Upstream Processes
• Downstream Processes
• Process Developments

Global Bioprocess Containers Market, By End User

• Pharmaceutical  & Biopharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes
• Others

Global Bioprocess Containers Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa